Fortress Biotech, Inc.FBIONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P97
Near historical high
vs 2Y Ago
1.6x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 77.83% |
| Q2 2025 | -40.88% |
| Q1 2025 | -51.57% |
| Q4 2024 | 35.65% |
| Q3 2024 | 8.15% |
| Q2 2024 | 13.98% |
| Q1 2024 | 27.33% |
| Q4 2023 | -108.21% |
| Q3 2023 | 49.60% |
| Q2 2023 | 22.97% |
| Q1 2023 | 9.66% |
| Q4 2022 | -10.56% |
| Q3 2022 | -4.46% |
| Q2 2022 | 11.60% |
| Q1 2022 | -21.10% |
| Q4 2021 | -78.36% |
| Q3 2021 | 37.04% |
| Q2 2021 | -58.89% |
| Q1 2021 | -5.87% |
| Q4 2020 | 14.26% |
| Q3 2020 | -37.22% |
| Q2 2020 | 20.46% |
| Q1 2020 | 12.61% |
| Q4 2019 | -54.03% |
| Q3 2019 | 42.57% |
| Q2 2019 | -11.83% |
| Q1 2019 | -20.52% |
| Q4 2018 | 6.75% |
| Q3 2018 | 18.73% |
| Q2 2018 | -0.55% |
| Q1 2018 | -15.14% |
| Q4 2017 | 8.28% |
| Q3 2017 | -9.28% |
| Q2 2017 | -108.23% |
| Q1 2017 | 36.15% |
| Q4 2016 | -103.68% |
| Q3 2016 | -19.52% |
| Q2 2016 | 36.56% |
| Q1 2016 | -506.75% |
| Q4 2015 | 143.77% |